Skip to main content
William Stohl, MD, Rheumatology, Los Angeles, CA

WilliamStohlMD

Rheumatology Los Angeles, CA

Professor, Medicine, USC School of Medicine

Dr. Stohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stohl's full profile

Already have an account?

  • Office

    101 The City Dr S
    Los Angeles, CA 92868
    Phone+1 323-442-1946
    Fax+1 323-442-2874

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1979 - 1982
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow American College of Rheumatology

Clinical Trials

Publications & Presentations

Press Mentions

  • Combo Biologic Therapy Makes Good in SLE
    Combo Biologic Therapy Makes Good in SLEOctober 26th, 2021
  • 2 Cases of SLE-Associated Diffuse Alveolar Hemorrage
    2 Cases of SLE-Associated Diffuse Alveolar HemorrageAugust 12th, 2021
  • COVID-19 Vaccines: Safe for Immunocompromised Patients?
    COVID-19 Vaccines: Safe for Immunocompromised Patients?December 17th, 2020
  • Join now to see all

Grant Support

  • The Vital Role Of BAFF In The Development Of SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
  • A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Ranging StudyNational Center For Research Resources2005–2008
  • T Cell Cytolytic Activity In SLENational Center For Research Resources1999–2002
  • T Cell Cytolytic Activity In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1997–2000
  • T-Cell Cytolytic Activity In SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1993–1995
  • Polymorphism Within T4/Leu3 And SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1987–1988
  • Polymorphism Within T4/Leu3 And SLENational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986

Professional Memberships